Yung NA
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
Health and Medical Research Fund
HMRF - Advanced Medical Research, Dapagliflozin combined with next-generation hormonal agent (NHA) versus single NHA in participants with metastatic castrate-resistant prostate cancer: a phase 2, multicenter, open-label, randomized controlled trial, 13241646, 2024, 1 Jan 2024
Sources: openalex.org